NDC 87625-101 - SurviveX Travel Med Kit
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 87625-101
- Manufacturer
- Intent Brands LLC
- Effective date
- 2026-05-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| SurviveX Travel Med Kit - Intent Brands LLC | Intent Brands LLC | 2026-05-07 | HUMAN OTC DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TYLENOL EXTRA STRENGTH | ACETAMINOPHEN | R J General Corporation | 99e45e83-37a3-44df-9a2a-98ba7457a5bb | 2025-11-17 | Warnings | M013 362O9ITL9D |
| TYLENOL PM EXTRA STRENGTH | ACETAMINOPHEN | R J General Corporation | a40ea0e3-d666-4605-b5e0-beeaf8f586f2 | 2025-11-17 | Warnings | M013 TC2D6JAD40 362O9ITL9D |
| Pepcid Complete | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | R J General Corporation | f0e08608-e9b0-3203-e053-2995a90adfbd | 2025-11-17 | Warnings | H0G9379FGK |
| Claritin | LORATADINE | R J General Corporation | a34e8cb7-4fdf-45be-b288-45d93eef6220 | 2025-11-17 | Warnings | 311372 7AJO3BO7QN |
| Acetaminophen 250 mg and Ibuprofen 125 mg | ACETAMINOPHEN 250 MG AND IBUPROFEN 125 MG | R J General Corporation | 68d3be55-9340-4cc9-a05a-12b9338ddc56 | 2025-11-17 | Warnings | M013 WK2XYI10QM 362O9ITL9D |
| Ibuprofen 200 mg | IBUPROFEN | R J General Corporation | dd9aaf80-6c2b-41a3-87b9-61642aaed4f0 | 2025-11-17 | Warnings | M013 310965 WK2XYI10QM |
| Ibuprofen 200 mg | IBUPROFEN | R J General Corporation | 1c18a2da-1718-4c00-aea8-9fb4a3418312 | 2025-11-17 | Warnings | M013 WK2XYI10QM |
| Ibuprofen 200 mg | IBUPROFEN | R J General Corporation | cd3060a5-3b90-42e4-89cd-3b620859045f | 2025-11-17 | Warnings | M013 310965 WK2XYI10QM |
| Ibuprofen 200 mg | IBUPROFEN | R J General Corporation | 1c7221ae-52d1-4d18-b586-c47ff656150d | 2025-11-17 | Warnings | M013 WK2XYI10QM |
| Excedrin Extra Strength Headache | ACETAMINOPHEN, ASPIRIN (NSAID), CAFFEINE | R J General Corporation | 907c89e7-2482-465f-9f85-2381ecab1b86 | 2025-11-17 | Warnings | M013 R16CO5Y76E 362O9ITL9D |
| Tums Antacid Chewy Bites | CALCIUM CARBONATE 750 MG | R J General Corporation | 6208d11d-0670-4a20-a3fc-ebc764a8e6cd | 2025-11-17 | Warnings | M001 H0G9379FGK |
| Theraflu Severe Cold Relief Daytime | ACETAMINOPHEN, DEXTROMETHORPHAN HBR | R J General Corporation | 8f0e4876-6bf0-4f6d-9cf0-f2aef2682ffc | 2025-11-17 | Warnings | M012 362O9ITL9D |
| Bayer Genuine Aspirin | ASPIRIN | R J General Corporation | 23daa359-d40f-4f64-81be-6d154f41df9f | 2025-11-17 | Warnings | M013 212033 R16CO5Y76E |
| Quality Choice Medicated Chest Rub | CAMPHOR, MENTHOL, EUCALYPTUS OIL | QUALITY CHOICE (Chain Drug Marketing Association) | c0e3c959-bed6-2ce5-e053-2995a90a0be9 | 2025-11-17 | Warnings | M012 |
| REGULAR STRENGTH ANTACID/ANTIGAS | ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, DIMETHICONE | RUGBY LABORATORIES | b244fce9-9626-e947-e053-2995a90ab8f9 | 2025-11-17 | Warnings | M001 |
| EXTRA STRENGTH PAIN RELIEVER | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | Geri-Care Pharmaceutical Corp | b670a898-2360-76e2-e053-2a95a90a3380 | 2025-11-17 | Warnings | M013 R16CO5Y76E 362O9ITL9D |
| Loratadine | LORATADINE | WALGREEN COMPANY | 3881afaf-8d0d-4154-85a8-79a3c7806b49 | 2025-11-17 | Warnings | 7AJO3BO7QN |
| MUCUS RELIEF | GUAIFENESIN | Geri-Care Pharmaceuticals, Corp | c5ea5a7a-c806-e5e0-e053-2995a90a15e9 | 2025-11-17 | Warnings | M012 |
| After Bite X Tech | SODIUM BICARBONATE | Adventure Ready Brands | e9e49ab4-3e1f-9fd4-e053-2a95a90a775a | 2025-11-17 | Warnings | 8MDF5V39QO |
| Multi-Symptom Flu HBP | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR | CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | 50f3157b-5788-4b63-835a-e60c8dc33df9 | 2025-11-17 | Warnings | M012 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.